Insulet | PODD - 债务

金融业

USD

USD 2.99B

现金及等价物

USD 480.4M

USD 232.7M

USD 1.71B

USD 687.5M

USD 949.2M

USD 122M

USD 181.7M

3.9K

EPS每股收益

USD 1.42

股本和储备

USD 1.3B

USD 540.8M

债务利息支出

USD 14.7M

USD 5.7M

USD 929.5M

USD 11.03B

USD 91.1M

USD 639.7M

USD 122M

普通股股本

USD 69.26M

38.83

USD 113M

USD 761.7M

销售和管理费用

USD 317.2M

USD 462.5M

贸易债权人

USD 149.8M

应收帐款人

USD 544.7M

	债务	更改		日
Abbott	USD 13.86B		919M	2025-12
Align Technology	USD 114.45M		6.82M	2025-12
AtriCure	USD 73.38M		3.35M	2025-12
Avanos Medical	USD 129.1M		4.6M	2025-12
Baxter International	USD 9.78B		68M	2025-12
Becton, Dickinson and Co.	USD 19.54B		358M	2025-12
Boston Scientific	USD 11.44B		610M	2025-12
Cardinal Health	USD 8.92B		111M	2026-03
Cooper Companies	USD 2.5B		5.6M	2025-12
Dexcom	USD 1.24B		900K	2026-03
Edwards Lifesciences	USD 600M		105.4M	2026-03
Eli Lilly	USD 42.5B		3.6M	2025-12
Globus Medical	USD 118.66M		687K	2025-12
ICU Medical	USD 1.28B		79.88M	2025-12
Inogen	USD 0		0	2022-06
Insulet	USD 949.2M		65.6M	2025-12
Integra LifeSciences	USD 2.04B		6.27M	2026-03
J&J	USD 47.93B		2.14B	2025-12
Medtronic	USD 28.07B		1.03B	2025-12
Merit Medical Systems	USD 821.57M		420K	2025-12
Roche Holding	CHF 33.03B		1.41B	2025-06
Solventum Corp	USD 7.91B		97M	2025-03
Stryker	USD 14.22B		635M	2026-03
Tandem Diabetes Care	USD 444.48M		4.81M	2025-12
Teleflex	USD 2.73B		43.5M	2025-12
West Pharmaceutical Services	USD 202.8M		0	2026-03
Zimmer Biomet Holdings	USD 7.47B		48.1M	2026-03